Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Molecular Complexity of Diffuse Large B-Cell Lymphoma: Can It Be a Roadmap for Precision Medicine?

Coccaro N, Anelli L, Zagaria A, Perrone T, Specchia G, Albano F.

Cancers (Basel). 2020 Jan 11;12(1). pii: E185. doi: 10.3390/cancers12010185. Review.

2.

Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial.

Bruna R, Benedetti F, Boccomini C, Patti C, Barbui AM, Pulsoni A, Musso M, Liberati AM, Gini G, Castellino C, Rossini F, Ciceri F, Rota-Scalabrini D, Stelitano C, Di Raimondo F, Tucci A, Devizzi L, Zoli V, Zallio F, Narni F, Dondi A, Parvis G, Semenzato G, Lanza F, Perrone T, Angrilli F, Billio A, Gueli A, Mantoan B, Rambaldi A, Gianni AM, Corradini P, Passera R, Ladetto M, Tarella C.

Haematologica. 2019 Nov;104(11):2241-2248. doi: 10.3324/haematol.2018.209932. Epub 2019 Apr 11.

3.

Pregnancy rate and outcome of pregnancies in long-term survivors of Hodgkin's lymphoma.

Gaudio F, Nardelli C, Masciandaro P, Perrone T, Laddaga FE, Curci P, Depalo R, Cicinelli E, Specchia G.

Ann Hematol. 2019 Aug;98(8):1947-1952. doi: 10.1007/s00277-019-03684-0. Epub 2019 Apr 17.

PMID:
30997537
4.

Delayed allergy to acyclovir revealed by lymphocyte proliferation test.

Albanesi M, Di Girolamo A, Aresta V, Rossi MP, Giliberti L, Perrone T, Di Bona D, Caiaffa MF, Specchia G, Macchia L.

Postepy Dermatol Alergol. 2018 Oct;35(5):527-529. doi: 10.5114/ada.2018.77244. Epub 2018 Jul 19. No abstract available.

5.

Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death.

Visco C, Tisi MC, Evangelista A, Di Rocco A, Zoellner AK, Zilioli VR, Hohaus S, Sciarra R, Re A, Tecchio C, Chiappella A, Morello L, Gini G, Nassi L, Perrone T, Molinari AL, Fabbri A, Cox MC, Finolezzi E, Ferrero S, Puccini B, Alvarez De Celis I, Arcari A, Marino D, Merli M, Piazza F, Gentile M, Pelosini M, Loseto G, Hermine O, Dreyling M, Ruggeri M, Martelli M, Hoster E, Vitolo U; Fondazione Italiana Linfomi and the Mantle Cell Lymphoma Network.

Br J Haematol. 2019 Jun;185(5):940-944. doi: 10.1111/bjh.15643. Epub 2018 Nov 8. No abstract available.

PMID:
30407625
6.

Bone Involvement in Hodgkin's Lymphoma: Clinical Features and Outcome.

Gaudio F, Pedote P, Niccoli Asabella A, Ingravallo G, Sindaco P, Alberotanza V, Perrone T, Laddaga FE, Rubini G, Stabile Ianora AA, Specchia G.

Acta Haematol. 2018;140(3):178-182. doi: 10.1159/000490489. Epub 2018 Oct 9.

7.

Brentuximab vedotin as salvage treatment in Hodgkin lymphoma naïve transplant patients or failing ASCT: the real life experience of Rete Ematologica Pugliese (REP).

Pavone V, Mele A, Carlino D, Specchia G, Gaudio F, Perrone T, Mazza P, Palazzo G, Guarini A, Loseto G, Eleonora P, Cascavilla N, Scalzulli P, Melpignano A, Quintana G, Di Renzo N, Tarantini G, Capalbo S.

Ann Hematol. 2018 Oct;97(10):1817-1824. doi: 10.1007/s00277-018-3379-5. Epub 2018 Jul 27.

PMID:
30054707
8.

Extralymphatic Disease Is an Independent Prognostic Factor in Hodgkin Lymphoma.

Gaudio F, Pedote P, Asabella AN, Perrone T, Laddaga FE, Sindaco P, Cimmino A, D'Abbicco D, Pezzolla A, Rubini G, Specchia G.

Clin Lymphoma Myeloma Leuk. 2018 Jun;18(6):e261-e266. doi: 10.1016/j.clml.2018.04.001. Epub 2018 Apr 14.

PMID:
29729983
9.

Assessment of DNA damages in lymphocytes of agricultural workers exposed to pesticides by comet assay in a cross-sectional study.

Intranuovo G, Schiavulli N, Cavone D, Birtolo F, Cocco P, Vimercati L, Macinagrossa L, Giordano A, Perrone T, Ingravallo G, Mazza P, Strusi M, Spinosa C, Specchia G, Ferri GM.

Biomarkers. 2018 Jul;23(5):462-473. doi: 10.1080/1354750X.2018.1443513. Epub 2018 Mar 2.

PMID:
29493297
10.

Computer-driven quantitative image analysis in the assessment of tumor cell and T cell features in diffuse large B cell lymphomas.

Gaudio F, Tamma R, Ingravallo G, Perrone T, Laddaga FE, De Candia M, Maiorano E, Ribatti D, Specchia G.

Ann Hematol. 2018 Apr;97(4):663-668. doi: 10.1007/s00277-017-3212-6. Epub 2018 Jan 23.

PMID:
29362889
11.

Risk of lymphoma subtypes by occupational exposure in Southern Italy.

Ferri GM, Specchia G, Mazza P, Ingravallo G, Intranuovo G, Guastadisegno CM, Congedo ML, Lagioia G, Loparco MC, Giordano A, Perrone T, Guadio F, Spinosa C, Minoia C, D'Onghia L, Strusi M, Corrado V, Cavone D, Vimercati L, Schiavulli N, Cocco P.

J Occup Med Toxicol. 2017 Nov 23;12:31. doi: 10.1186/s12995-017-0177-2. eCollection 2017.

12.

T cells, mast cells and microvascular density in diffuse large B cell lymphoma.

Marinaccio C, Ingravallo G, Gaudio F, Perrone T, Ruggieri S, Opinto G, Nico B, Maiorano E, Specchia G, Ribatti D.

Clin Exp Med. 2016 Aug;16(3):301-6. doi: 10.1007/s10238-015-0354-5. Epub 2015 May 10.

PMID:
25957593
13.

Microvascular density, CD68 and tryptase expression in human diffuse large B-cell lymphoma.

Marinaccio C, Ingravallo G, Gaudio F, Perrone T, Nico B, Maoirano E, Specchia G, Ribatti D.

Leuk Res. 2014 Nov;38(11):1374-7. doi: 10.1016/j.leukres.2014.09.007. Epub 2014 Sep 22.

PMID:
25293515
14.

CT-guided needle biopsy performed with modified coaxial technique in patients with refractory or recurrent lymphomas.

Gaudio F, Pedote P, Ferrante A, Perrone T, Ingravallo G, Ianora AA, Angelelli G, Specchia G.

Ann Hematol. 2014 Sep;93(9):1559-64. doi: 10.1007/s00277-014-2078-0. Epub 2014 Apr 24.

PMID:
24760400
15.

Computed tomography-guided needle biopsy performed with modified coaxial technique in patients with suspected lymphoma.

Gaudio F, Pedote P, Ferrante A, Perrone T, Ingravallo G, Stabile Ianora AA, Angelelli G, Specchia G.

Leuk Lymphoma. 2014 Aug;55(8):1949-51. doi: 10.3109/10428194.2013.867488. Epub 2014 Jan 28. No abstract available.

PMID:
24255980
16.

Peripheral blood CD4/CD19 cell ratio is an independent prognostic factor in classical Hodgkin lymphoma.

Gaudio F, Perrone T, Mestice A, Curci P, Giordano A, Delia M, Pastore D, Specchia G.

Leuk Lymphoma. 2014 Jul;55(7):1596-601. doi: 10.3109/10428194.2013.854889. Epub 2014 Feb 4.

PMID:
24164533
17.

Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program.

Ladetto M, Lobetti-Bodoni C, Mantoan B, Ceccarelli M, Boccomini C, Genuardi E, Chiappella A, Baldini L, Rossi G, Pulsoni A, Di Raimondo F, Rigacci L, Pinto A, Galimberti S, Bari A, Rota-Scalabrini D, Ferrari A, Zaja F, Gallamini A, Specchia G, Musto P, Rossi FG, Gamba E, Evangelista A, Vitolo U; Fondazione Italiana Linfomi.

Blood. 2013 Nov 28;122(23):3759-66. doi: 10.1182/blood-2013-06-507319. Epub 2013 Oct 1.

18.

Outcome of allogeneic peripheral blood stem cell transplantation by donor graft CD3+/Tregs ratio: a single-center experience.

Delia M, Pastore D, Mestice A, Carluccio P, Perrone T, Gaudio F, Ricco A, Sgherza N, Albano F, Specchia G.

Biol Blood Marrow Transplant. 2013 Mar;19(3):495-9. doi: 10.1016/j.bbmt.2012.11.015. Epub 2012 Nov 27.

19.

CD3+/Tregs ratio in donor grafts is linked to acute graft-versus-host disease and immunologic recovery after allogeneic peripheral blood stem cell transplantation.

Pastore D, Delia M, Mestice A, Carluccio P, Perrone T, Gaudio F, Curci P, Rossi AR, Ricco A, Specchia G.

Biol Blood Marrow Transplant. 2012 Jun;18(6):887-93. doi: 10.1016/j.bbmt.2011.10.039. Epub 2011 Nov 4.

20.

High Ki67 index and bulky disease remain significant adverse prognostic factors in patients with diffuse large B cell lymphoma before and after the introduction of rituximab.

Gaudio F, Giordano A, Perrone T, Pastore D, Curci P, Delia M, Napoli A, de' Risi C, Spina A, Ricco R, Liso V, Specchia G.

Acta Haematol. 2011;126(1):44-51. doi: 10.1159/000324206. Epub 2011 Mar 24.

PMID:
21430371

Supplemental Content

Loading ...
Support Center